CLINICAL_TRIALS
trial_result
· 2019-01-29
Clinical Trial Update: Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine [Phase 3]
Summary
Phase 3 trial update on oral ubrogepant for acute treatment of migraine assessing efficacy, safety, and tolerability.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Migraine, With or Without Aura | Phase 3 | Status: COMPLETED | Results posted: 2019-01-29